Literature DB >> 8743761

Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators.

M J Reiter1, D E Mann.   

Abstract

Sensing of cardiac activity and detection of tachyarrhythmias in implantable cardioverter defibrillators (ICDs) are complex functions and errors occur. Sources of sensing-detection errors include the variable nature of intracardiac electrograms, the occasional inability of automatically adjusting signal amplifiers to cope with this variability, problems with sensing leads, inappropriate programming, and limitations of tachyarrhythmia detection algorithms, which are optimized to avoid underdetection of ventricular tachyarrhythmias. Current ICDs vary considerably in details of sensing and detection function, programmability, and diagnostic data, so that a through knowledge of each device is necessary to diagnose and correct these problems. Stored intracardiac electrograms and/or marker channels available in most of these devices have contributed much to our understanding of sensing-detection errors. Undersensing of individual signals, most frequently due to signal variability and/or inability of the amplifier to adjust adequately, can lead to delay or failure of tachyarrhythmia detection. Delay or failure of tachyarrhythmia detection can also occur if algorithms to enhance specificity, such as sudden onset or rate stability, are utilized. Oversensing of T waves or noise can lead to false detection; however, the most common cause of false detection is the inability of current detection algorithms to distinguish supraventricular from ventricular tachyarrhythmias. New algorithms that incorporate atrial sensing, electrogram morphology analysis, or hemodynamic monitoring may result in improved detection accuracy of ICDs in the future.

Entities:  

Mesh:

Year:  1996        PMID: 8743761     DOI: 10.1111/j.1540-8167.1996.tb00562.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

Review 1.  New devices and hybrid therapies and new devices for treatment of atrial fibrillation.

Authors:  R B Krol; S Saksena; A Prakash
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

2.  Inappropriate implantable defibrillator discharge caused by a retained pacemaker lead fragment.

Authors:  L Lickfett; C Wolpert; W Jung; S Spehl; L Pizzulli; B Esmailzadeh; B Lüderitz
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

3.  Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials.

Authors:  R W Peters; M Cooklin; R Brockman; S R Shorofsky; M R Gold
Journal:  J Interv Card Electrophysiol       Date:  1998-12       Impact factor: 1.900

Review 4.  Interactions of antiarrhythmic drugs with implantable defibrillator therapy for atrial and ventricular tachyarrhythmias.

Authors:  R B Krol; S Saksena; A Prakash
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.